1. Home
  2. SANM vs IOVA Comparison

SANM vs IOVA Comparison

Compare SANM & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanmina Corporation

SANM

Sanmina Corporation

HOLD

Current Price

$160.81

Market Cap

6.2B

Sector

Technology

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.21

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANM
IOVA
Founded
1980
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
968.6M
IPO Year
1993
N/A

Fundamental Metrics

Financial Performance
Metric
SANM
IOVA
Price
$160.81
$2.21
Analyst Decision
Hold
Buy
Analyst Count
1
12
Target Price
$120.00
$10.36
AVG Volume (30 Days)
618.3K
9.7M
Earning Date
01-26-2026
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
14.07
N/A
EPS
4.46
N/A
Revenue
$8,128,382,000.00
$250,425,000.00
Revenue This Year
$75.74
$60.94
Revenue Next Year
$12.92
$60.85
P/E Ratio
$35.99
N/A
Revenue Growth
7.40
175.62
52 Week Low
$63.67
$1.64
52 Week High
$178.39
$8.56

Technical Indicators

Market Signals
Indicator
SANM
IOVA
Relative Strength Index (RSI) 53.06 46.56
Support Level $157.25 $2.18
Resistance Level $177.00 $2.32
Average True Range (ATR) 7.72 0.12
MACD 0.50 -0.01
Stochastic Oscillator 49.41 18.11

Price Performance

Historical Comparison
SANM
IOVA

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue primarily in the United States, China, and Mexico, but has a presence around the world.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: